Moreover, HHT and MLKL inhibitor NSA noticeably cooperated in inhibiting clonogenic survival of CRC cells DLD1, HCT116, LS180 and SW480 (Fig. 1G–J). The gene discussed is MLKL; the disease is colorectal carcinoma.